Dr Katie Heath
Senior Research Officer
Working groups
Background
Dr Katie Heath MA MSc DPhil is a Senior Research Officer under the Viral Hepatitis Elimination Program.
Her work centres on equitable healthcare access with a focus on HIV, viral hepatitis and syphilis. She targets health systems and policy reform to improve healthcare access.
Dr Heath completed a PhD in 2019, which focussed on mosquito-borne disease control in the context of climate change. At the Burnet Institute, her work on hepatitis C aims to improve treatment uptake using rapid tests and her work on COVID-19 considered the impact of public health orders.
Dr Heath is a consultant with the World Health Organization under the Department of Global HIV, Hepatitis and STIs Programmes, where she develops tools and policy for national strategic planning in maternal and child health. She is also an independent consultant advocating for equitable drug pricing and treatment access.
Qualifications
- 2019 - PhD Zoology, University of Oxford
- 2014 - MSc Epidemiology, Imperial College London
- 2013 - BA Philosophy, University of Cambridge
Positions
- 2022-ongoing – Senior Research Officer, Burnet Institute, Melbourne, Australia
- 2020-2022 – Research Officer, Burnet Institute, Melbourne, Australia
- 2018-ongoing: Consultant, World Health Organization, Department of Reproductive Health & Research, Geneva, Switzerland
- 2018-2018: Environmental Scientist, Instituto Nacional de Pesquisas Espaciais (INPE), São José dos Campos, Brazil
- 2016: Scientific Enterprise Consultant, The Nasio Trust, Musanda, Western, Kenya
- 2014-2015: Research Officer, International Prevention Research Institute (IPRI), Lyon, France
- 2012: Research Assistant, University of Strathclyde, Department of Mathematics and Statistics, Glasgow, UK
Reports and other work
-
The Optimise Study: A rapid survey examining frequency, impacts of long COVID and associated concerns. (PUBLIC HEALTH REPORT)
Long COVID is estimated to be costing the Australian economy $3.6 billion annually.1 Partly because of the variation in the definition of long COVID
The Optimise Study: A rapid survey examining frequency, impacts of long COVID and associated concerns. (PUBLIC HEALTH REPORT) -
The Optimise Study:- Impacts of the COVID-19 response on culturally and linguistically diverse communities. (PUBLIC HEALTH REPORT)
The Optimise Study:- Impacts of the COVID-19 response on culturally and linguistically diverse communities. (PUBLIC HEALTH REPORT) -
COVID-19 testing and vaccination. (PUBLIC HEALTH REPORT)
COVID-19 testing and vaccination. (PUBLIC HEALTH REPORT)
-
The Optimise Study: Social networks and mixing patterns. (PUBLIC HEALTH REPORT)
The Optimise Study: Social networks and mixing patterns. (PUBLIC HEALTH REPORT) -
The Optimise Study: Social networks and mixing patterns
This report focuses on: Average overall contacts between October 2020 and March 2021, Average contacts per setting, over time, The impact of contacts on mood and the influence of people's social network on attitudes toward vaccination.
The Optimise Study: Social networks and mixing patterns -
The Optimise Study: A rapid survey examining the influence of potential cessation of the Victorian pandemic declaration. (PUBLIC HEALTH REPORT)
The Optimise Study: A rapid survey examining the influence of potential cessation of the Victorian pandemic declaration. (PUBLIC HEALTH REPORT) -
The Optimise Study: COVID-19 testing, test positivity and contacts over time. (PUBLIC HEALTH REPORT)
The Optimise Study: COVID-19 testing, test positivity and contacts over time. (PUBLIC HEALTH REPORT) -
The Optimise Study: Vaccination knowledge, attitudes and beliefs. (PUBLIC HEALTH REPORT)
The Optimise Study: Vaccination knowledge, attitudes and beliefs. (PUBLIC HEALTH REPORT) -
The Optimise Study: COVID-19 related worry, acceptability of prevention measures and confidence in Government. (PUBLIC HEALTH REPORT)
The Optimise Study: COVID-19 related worry, acceptability of prevention measures and confidence in Government. (PUBLIC HEALTH REPORT) -
The Optimise Study: Impact of government restrictions on risk mitigation strategies. (PUBLIC HEALTH REPORT)
The Optimise Study: Impact of government restrictions on risk mitigation strategies. (PUBLIC HEALTH REPORT)
Burnet publications
View 17 moreBalancing Efficiency and Accuracy in Hepatitis C Rapid Antibody Testing: Insights From a Cluster Randomised Crossover Trial
Journal of Viral Hepatitis
Katherine Heath et al
Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (the QuickStart Study): a cluster randomised cross-over trial protocol
BMJ Open
Joseph Doyle et al
WHO hepatitis C elimination targets: the global equity challenge
˜The œLancet. Gastroenterology & hepatology
Katherine Heath, Andrew Hill
Past projects
The elimination of hepatitis C as a global public health threat
This project addresses critical knowledge gaps in Australian and global efforts to eliminate hepatitis C as a public health threat by 2030.
The Optimise Study: Optimising Isolation, Quarantine and Distancing for COVID-19
This project aims to find out how Victorians are experiencing COVID-19 and responding to the measures introduced to stop the spread of the virus.